Oncolytics Biotech Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Oncolytics Biotech Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- Canada
- Ticker symbol
- ONCY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001129928
Board of directors
-
Angela Holtham · DirectorSince 2026
-
Bernd R. Seizinger · DirectorSince 2026
-
Deborah Margaret Brown · DirectorSince 2026
-
James T. Parsons · DirectorSince 2026
-
Jared Kelly · Director · Chief Executive OfficerSince 2026
-
Jonathan Rigby · DirectorSince 2026
-
Patricia S. Andrews · DirectorSince 2026
-
Stephen C. Glover · DirectorSince 2026
-
Wayne Pisano · DirectorSince 2026
Chief executives
Jared Kelly
· Chief Executive Officer
Since January 2026
Board connections
5 of this board's directors also sit on 6 other boards.
- via Wayne Pisano
- via Bernd R. Seizinger
- via Patricia S. Andrews
- via James T. Parsons
- via Patricia S. Andrews
- via Stephen C. Glover
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $363,232
- 14 purchases by 10 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Jared Kelly Director, Officer (Chief Executive Officer) | Open-market purchase | +5,050 | $0.96 | $4,848 |
| Mar 11, 2026 | James T. Parsons Director | Open-market purchase | +10,000 | $1.03 | $10,300 |
| Feb 12, 2026 | Look Kirk Officer (Chief Financial Officer) | Open-market purchase | +12,000 | $0.84 | $10,080 |
| Feb 12, 2026 | Wayne Pisano Director | Open-market purchase | +30,000 | $0.84 | $25,200 |
| Feb 12, 2026 | Heineman Thomas Charles Officer (Chief Medical Officer) | Open-market purchase | +12,132 | $0.83 | $10,070 |
| Feb 12, 2026 | Deborah Margaret Brown Director | Open-market purchase | +25,000 | $0.85 | $21,250 |
| Feb 12, 2026 | Hagerman Allison Officer (VP, Product Development) | Open-market purchase | +10,000 | $0.83 | $8,300 |
| Feb 12, 2026 | Patricia S. Andrews Director | Open-market purchase | +35,400 | $0.86 | $30,444 |
| Feb 12, 2026 | Bernd R. Seizinger Director | Open-market purchase | +40,000 | $0.85 | $34,000 |
| Feb 12, 2026 | Jared Kelly Director, Officer (Chief Executive Officer) | Open-market purchase | +29,500 | $0.84 | $24,780 |
| Feb 11, 2026 | Bernd R. Seizinger Director | Open-market purchase | +60,000 | $0.83 | $49,800 |
| Feb 11, 2026 | Aromando Andrew Officer (Chief Business Officer) | Open-market purchase | +29,600 | $0.86 | $25,456 |
| Feb 11, 2026 | Jared Kelly Director, Officer (Chief Executive Officer) | Open-market purchase | +5,600 | $0.84 | $4,704 |
| Jan 16, 2026 | Bernd R. Seizinger Director | Open-market purchase | +100,000 | $1.04 | $104,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.